Delivery Order SPE2DB20D2104-SPE2DB22FR50F
- Not listed
- This federal contract award is for the delivery of EpiPen 2-Pak 0.3 mg auto-injectors to the U.S. Department of Defense (DoD) and its military healthcare programs. The contract, valued at $2,146.92, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order valued at $2,928.65 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of EpiPen 2-Pak 0.3 mg auto-injectors. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of EpiPen 2-Pak 0.3 mg auto-injectors to support the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,284.41, is a firm fixed-price delivery order with a completion date of March 30, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of EpiPen 2-Pak 0.3 mg auto-injectors. The $1,290.08 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 17, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of EpiPen 2-Pak 0.3 mg auto-injectors, a critical medication used to treat severe allergic reactions. The contract has a ceiling value of $3,983.84 and a completion date of January 13, 2023. It is a firm-fixed-price contract, with no set-aside designation, indicating open...
- This federal contract award for $1,427.51 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of EPIPEN 2-PAK 0.3 MG AUTO-INJCT 2S. This is a delivery order under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of EpiPen 2-Pak 0.3 mg auto-injectors. The Firm Fixed Price Delivery Order, valued at $1,314.00, has an ultimate completion date of April 24, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EpiPen 2-Pak 0.3 mg auto-injectors. The contract, valued at $2,007.61, has a completion date of May 3, 2023 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of EpiPen 2-Pak 0.3 mg auto-injectors. The $2,493.06 Firm Fixed Price delivery order, awarded on September 23, 2021, has a completion date of September 24, 2021. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $29,009.68, is for the delivery of EpiPen 2-Pak 0.3 mg auto-injectors. This is a firm fixed-price delivery order contract with an ultimate completion date of December 20, 2022. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of prescription...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FR50FDelivery Order
This federal contract award is for the delivery of EpiPen 2-Pak 0.3 mg auto-injectors, valued at $1,935.00, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract is a delivery order (SPE2DB22FR50F) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA IDC, Cencora, Inc. holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs demonstrate Cencora, Inc.'s ability to efficiently fulfill the diverse pharmaceutical and medical supply needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 1/12/22 |